Daiwa Securities Group Inc. Keros Therapeutics, Inc. Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
A detailed history of Daiwa Securities Group Inc. transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 133 shares of KROS stock, worth $8,026. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133
Previous 133
-0.0%
Holding current value
$8,026
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding KROS
# of Institutions
173Shares Held
30.3MCall Options Held
67.6KPut Options Held
9K-
Black Rock Inc. New York, NY2.51MShares$152 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.9MShares$115 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$112 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.52MShares$92 Million7.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.51MShares$91.4 Million0.01% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.55B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...